Simavi Vahip, Turkey
Ege University Medicine Faculty Department of PsychiatryPresenter of 4 Presentations
Board Meeting
- Julian Beezhold, United Kingdom
- Geert Dom, Belgium
- Peter Falkai, Germany
- Andrea Fiorillo, Italy
- Silvana Galderisi, Italy
- Philip A. Gorwood, France
- Cecile Hanon, France
- Hilkka M. Kärkkäinen, Finland
- Tamas Kurimay, Hungary
- Miia Männikkö, Finland
- Diego Palao Vidal, Spain
- Mariana Pinto da Costa, United Kingdom
- Andrea Raballo, Italy
- Martina Rojnic-Kuzman, Croatia
- Meryam Schouler-Ocak, Germany
- Agata Szulc, Poland
- Danuta Wasserman, Sweden
- Michael E. Wise, United Kingdom
- Simavi Vahip, Turkey
- Julian Beezhold, United Kingdom
- Geert Dom, Belgium
- Peter Falkai, Germany
- Andrea Fiorillo, Italy
- Silvana Galderisi, Italy
- Philip A. Gorwood, France
- Cecile Hanon, France
- Hilkka M. Kärkkäinen, Finland
- Tamas Kurimay, Hungary
- Miia Männikkö, Finland
- Diego Palao Vidal, Spain
- Mariana Pinto da Costa, United Kingdom
- Andrea Raballo, Italy
- Martina Rojnic-Kuzman, Croatia
- Meryam Schouler-Ocak, Germany
- Agata Szulc, Poland
- Danuta Wasserman, Sweden
- Michael E. Wise, United Kingdom
- Simavi Vahip, Turkey
Executive Committee Meeting
Optimal interaction within the Mental Health Workforces in the post-Covid times: European and international institutional and non-governmental views Roundtable discussion:
The Name “Schizophrenia”: Initiatives and Proposals from the National Psychiatric Associations - W049
Abstract
Abstract Body
Renaming schizophrenia which started from Japan has received heterogeneous reactions from all over the world. Some countries, associations and experts consider it as an opportunity to fight against stigma while others do not share this perspective. Reactions, initiatives and proposals collected from EPA (European Psychiatric Association) member National Psychiatric Associations (NPAs) will be summarized to facilitate the discussion. A survey, consisting of structured and semi-structured questions was sent to 44 EPA member NPAs from 40 countries. Main purpose of the survey was to search and collect the NPAs’ opinions on several perspectives including any previous or planned action for this issue, possible prediction on whether renaming could be effective on stigmatization in their countries and cultures, and any proposals as possible new names for schizophrenia. Also, NPAs had been requested to provide evaluations of their Psychosis or Schizophrenia Section members, or other experts from their countries via the same instrument. The collected data will be presented in this workshop to facilitate the discussion and to elaborate Europe-wide or country specific positions and needs on the issue.